Nautilus Biotechnology, Inc. (NAUT) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
NAUT Revenue Analysis (2018–2025)
As of March 5, 2026, Nautilus Biotechnology, Inc. (NAUT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, NAUT's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including CAI (+144.9% YoY), VCYT (+16.0% YoY), and ADPT (+42.6% YoY). Compare NAUT vs CAI →
Peer Comparison
Compare NAUT's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NAUTCurrent | $0 | - | - | - | |
 CAI | $812M | +144.9% | +14.3% | 5.6% | |
 VCYT | $517M | +16.0% | +34.5% | 11.2% | |
 ADPT | $179M | +42.6% | +16.0% | -90.8% | |
 CDIO | $34,890 | -55.8% | - | -23977.9% | |
 SEER | $14M | +14.5% | +160.6% | -717.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $0 | - |
| 2024 | $0 | - | $-6,353,000 | - | $-81,476,000 | - |
| 2023 | $0 | - | $-5,705,000 | - | $-76,152,000 | - |
| 2022 | $0 | - | $-3,416,000 | - | $-63,618,000 | - |
| 2021 | $0 | - | $-2,842,000 | - | $-50,498,000 | - |
| 2020 | $0 | - | $-2,346,000 | - | $-15,744,000 | - |
| 2019 | $0 | - | $0 | - | $-10,110,000 | - |
| 2018 | $0 | - | $0 | - | $-111,684,000 | - |
See NAUT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NAUT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare NAUT vs LLY
See how NAUT stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is NAUT's revenue growth accelerating or slowing?
NAUT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NAUT's long-term revenue growth rate?
Nautilus Biotechnology, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is NAUT's revenue distributed by segment?
NAUT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.